Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Swedish medical technology company RaySearch Laboratories and TomoTherapy, a US-based developer of radiation therapy system, have announced that the new software solution SharePlan has received 510(k) clearance from the FDA and can now be market launched.
Subscribe to our email newsletter
SharePlan is an advanced treatment planning solution that enables transfer of treatment plans between TomoTherapy HiArt systems and conventional linear accelerators. The product uses highly sophisticated algorithms to automatically generate a selection of deliverable high-quality IMRT plans based on an existing HiArt plan, the companies said.
This time-saving concept is an important tool for optimizing patient benefit and throughput at clinics that are introducing a HiArt system into an environment with existing conventional linear accelerators, the companies added.
Del Coufal, vice president of marketing at TomoTherapy, said: “We understand how important it is for TomoTherapy technology to seamlessly integrate into a cancer center, regardless of the type of surrounding equipment the center also uses. By aligning with RaySearch, we are able to make it easy for any center to easily adopt our radiotherapy system.”